24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Trametinib
Related studies linked through entity extraction aliases.
Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
MRD-positive AML Clinical Study
- Status
- RECRUITING
- Phase
- NA
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
- Status
- RECRUITING
- Phase
- PHASE2
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Status
- RECRUITING
- Phase
- PHASE1
Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pediatric Long-Term Follow-up and Rollover Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Pan Tumor Rollover Study
- Status
- RECRUITING
- Phase
- PHASE2
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Molecular Profiling of Advanced Soft-tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE3
Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Dabrafenib and/or Trametinib Rollover Study
- Status
- RECRUITING
- Phase
- PHASE4